![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MIR24-2 |
Gene summary for MIR24-2 |
![]() |
Gene information | Species | Human | Gene symbol | MIR24-2 | Gene ID | 407013 |
Gene name | microRNA 24-2 | |
Gene Alias | MIRN24-2 | |
Cytomap | 19p13.12 | |
Gene Type | ncRNA | GO ID | GO:0008150 | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
407013 | MIR24-2 | P1_S1_AK | Human | Skin | AK | 2.08e-05 | -1.94e-01 | -0.3399 |
407013 | MIR24-2 | P2_S3_AK | Human | Skin | AK | 2.08e-05 | -1.94e-01 | -0.3287 |
407013 | MIR24-2 | P2_S4_SCCIS | Human | Skin | SCCIS | 9.75e-06 | -1.94e-01 | -0.3043 |
407013 | MIR24-2 | P3_S6_AK | Human | Skin | AK | 2.08e-05 | -1.94e-01 | -0.3256 |
407013 | MIR24-2 | P4_S8_cSCC | Human | Skin | cSCC | 1.45e-02 | -1.94e-01 | -0.3095 |
407013 | MIR24-2 | P5_S10_cSCC | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.299 |
407013 | MIR24-2 | P1_cSCC | Human | Skin | cSCC | 2.85e-25 | 1.31e+00 | 0.0292 |
407013 | MIR24-2 | P2_cSCC | Human | Skin | cSCC | 2.80e-45 | 1.56e+00 | -0.024 |
407013 | MIR24-2 | P4_cSCC | Human | Skin | cSCC | 2.76e-57 | 1.35e+00 | -0.00290000000000005 |
407013 | MIR24-2 | P10_cSCC | Human | Skin | cSCC | 8.60e-22 | 9.71e-01 | 0.1017 |
407013 | MIR24-2 | cSCC_p1 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.1916 |
407013 | MIR24-2 | cSCC_p10 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.2095 |
407013 | MIR24-2 | cSCC_p11 | Human | Skin | cSCC | 4.43e-05 | -1.94e-01 | -0.2102 |
407013 | MIR24-2 | cSCC_p3 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.2085 |
407013 | MIR24-2 | cSCC_p4 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.2022 |
407013 | MIR24-2 | cSCC_p6 | Human | Skin | cSCC | 9.75e-06 | -1.94e-01 | -0.1989 |
407013 | MIR24-2 | cSCC_p7 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.2332 |
407013 | MIR24-2 | cSCC_p8 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.1971 |
407013 | MIR24-2 | cSCC_p9 | Human | Skin | cSCC | 2.08e-05 | -1.94e-01 | -0.1991 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |